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Abstract
The heterochromatic environment and physical clustering of chromosome ends at the nuclear periphery provide a
functional and structural framework for antigenic variation and evolution of subtelomeric virulence gene families in the
malaria parasite Plasmodium falciparum. While recent studies assigned important roles for reversible histone modifications,
silent information regulator 2 and heterochromatin protein 1 (PfHP1) in epigenetic control of variegated expression, factors
involved in the recruitment and organization of subtelomeric heterochromatin remain unknown. Here, we describe the
purification and characterization of PfSIP2, a member of the ApiAP2 family of putative transcription factors, as the unknown
nuclear factor interacting specifically with cis-acting SPE2 motif arrays in subtelomeric domains. Interestingly, SPE2 is not
bound by the full-length protein but rather by a 60kDa N-terminal domain, PfSIP2-N, which is released during schizogony.
Our experimental re-definition of the SPE2/PfSIP2-N interaction highlights the strict requirement of both adjacent AP2
domains and a conserved bipartite SPE2 consensus motif for high-affinity binding. Genome-wide in silico mapping
identified 777 putative binding sites, 94% of which cluster in heterochromatic domains upstream of subtelomeric var genes
and in telomere-associated repeat elements. Immunofluorescence and chromatin immunoprecipitation (ChIP) assays
revealed co-localization of PfSIP2-N with PfHP1 at chromosome ends. Genome-wide ChIP demonstrated the exclusive
binding of PfSIP2-N to subtelomeric SPE2 landmarks in vivo but not to single chromosome-internal sites. Consistent with
this specialized distribution pattern, PfSIP2-N over-expression has no effect on global gene transcription. Hence, contrary to
the previously proposed role for this factor in gene activation, our results provide strong evidence for the first time for the
involvement of an ApiAP2 factor in heterochromatin formation and genome integrity. These findings are highly relevant for
our understanding of chromosome end biology and variegated expression in P. falciparum and other eukaryotes, and for
the future analysis of the role of ApiAP2-DNA interactions in parasite biology.
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Introduction
Throughout the eukaryotic kingdom, the overall structure of
chromosome ends is conserved and characterized by the telomeric
tract, composed of short G-rich repeats, and an extensive
subtelomeric region consisting of various types and lengths of
repeats, also known as telomere-associated sequences (TAS) [1].
This conservation underscores the functional importance of these
domains in genome function and maintenance. Due to the
heterochromatic nature of subtelomeric regions, genes located
nearby are subject to epigenetic control and variegated expression
[2–5]. Furthermore, subtelomeric domains promote frequent
recombination events driving the evolution and diversity of gene
families located close to chromosome ends [1,3]. Pathogenic
microorganisms exploit this system for antigenic variation of
surface antigens to evade adaptive immune responses or to
respond to other changes in environmental conditions [6].
The apicomplexan parasite Plasmodium falciparum causes the
most severe form of malaria in humans with up to two million
deaths annually [7]. Malaria symptoms are entirely associated with
the erythrocytic phase of infection where repeated rounds of intra-
erythrocytic parasite multiplication take place. Sequestration of
infected red blood cell aggregates in the microvasculatory system,
which is mediated by the binding of P. falciparum erythrocyte
membrane protein 1 (PfEMP1) to a variety of endothelial
receptors [8–11], represents one of the main contributors to
severe disease, including cerebral and placental malaria [12–14].
PfEMP1 is encoded by the var gene family comprising approx. 60
mostly subtelomeric members [15–18]. Importantly, due to
mutually exclusive transcription of var genes, only one PfEMP1
variant is exposed per parasite at any time and switches in var gene
expression result in antigenic variation of PfEMP1 [17,19]
facilitating immune evasion and chronic infection. Recent studies
highlighted the important contribution of the specific biology and
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dynamics of heterochromatic chromosome ends in the regulation
of var genes and additional subtelomeric gene families coding for
proteins involved in host-parasite interactions [20–27].
P. falciparum chromosome ends consist of a stretch of telomeric
GGGTT(T/C)A repeats with an average size of 1.2 kb, followed
by an extensive 20 to 40 kb TAS domain [28]. This region is
composed of a conserved arrangement of so-called telomere-
associated repeat elements (TAREs 1 to 6), each of which consists
of distinct non-coding repeat arrays of varying length and
sequence [29]. On all chromosome ends, the coding part of the
genome directly downstream of TARE 6 is characterized by
members of multiple antigen gene families including var, rif, stevor
and pfmc-2tm [18]. Similar to other unicellular eukaryotes, P.
falciparum chromosome ends associate into clusters that are
anchored to the nuclear periphery [30–32]. This structurally
conserved context facilitates meiotic recombination between var
genes on heterologous chromosomes [30]. Interestingly, sponta-
neous chromosome breakage and telomere healing events create
chromosome ends lacking the entire TARE region; while such
chromosomes are still tethered to the nuclear periphery, they
display a reduced association with other chromosome ends
implicating a role for TARE in cluster formation [33].
Expression of P. falciparum subtelomeric gene families is clonally
variant and restricted to only one member (or a few) in each family
[19,34–36]. Transgenes inserted into TARE 6 as well as
endogenous var genes are reversibly silenced in a manner
reminiscent to telomere-postion effect in other eukaryotes [25].
Recent genome-wide studies highlighted the striking and exclusive
association of the repressive histone 3 lysine 9 tri-methylation mark
(H3K9me3) and heterochromatin protein 1 (PfHP1) throughout
the TAS region and adjacent gene families on all chromosomes
[23,27,37]. These heterochromatic marks are also important in
telomere-proximal gene silencing in S. pombe and higher eukaryotes
[38,39], indicating the existence of conserved epigenetic control
strategies in highly divergent eukaryotes. The epigenetic changes
underlying mutually exclusive var gene transcription and switching
have been studied in some detail. Active var loci are enriched in
acetylated H3K9 and H3K4me2/me3 [21], and the process of
activation is linked to locus repositioning into an ill-defined
transcriptionally active zone at the nuclear periphery [24,31,40].
Silenced var loci lack these activation marks and are enriched in
H3K9me3 and PfHP1 instead [21,22,41]. Furthermore, silencing
of var and a subset of rif genes is dependent on the two P. falciparum
orthologs of silent information regulator 2 (PfSIR2) [20,25,26].
Overall, these results show that conserved epigenetic mecha-
nisms that are also in place in other eukaryotes dictate
heterochromatic silencing in P. falciparum. However, it remains
completely unknown which proteins and cis-acting sequences are
involved in the recruitment and organization of P. falciparum
heterochromatin, and how they contribute to the important role of
chromosome end biology in this pathogen. Our understanding of
sequence-specific DNA-protein interactions in P. falciparum is
negligible and mostly limited to the description of upstream
sequence elements and their interaction with unknown nuclear
proteins, and to in silico mapping of over-represented motifs in
candidate promoter sequences [42]. This lack of knowledge is
related to the extreme diversity of specific DNA-binding proteins
in eukaryotes and the poor representation of such factors in the
apicomplexan lineage [43–45]. Until recently, PfMYB1 was the
only sequence-specific DNA-binding protein that had been
investigated to some extent in vivo [46]. New impulses were given
by the discovery of the lineage-specific expansion of the ApiAP2
family of putative transcription factors in apicomplexan parasites,
characterized by the presence of plant-like AP2 DNA-binding
domains [47]. The binding of three parasite AP2 domains to
specific cis-acting elements upstream of P. falciparum genes in vitro
has recently been demonstrated [48], and another study described
an essential role for PbAP2-O in stage-specific transcription in P.
berghei ookinetes [49].
Here, we identified a member of the ApiAP2 family as the
unknown protein binding to SPE2 arrays upstream of subtelo-
meric var genes at the border of the non-coding and coding parts of
P. falciparum chromosomes [50]. The SPE2-interacting protein,
termed PfSIP2, contains two adjacent AP2 domains and is
proteolytically processed in vivo to release a 60kDa functional N-
terminal domain, PfSIP2-N. We show that both AP2 domains are
strictly required for binding to the bipartite SPE2 motif. In vivo,
PfSIP2-N is associated with over 700 SPE2 consensus sites that
cluster upstream of subtelomeric var genes and in TARE2/3, but
not to single chromosome internal sites. Consistent with this
striking and exclusive binding of PfSIP2-N to heterochromatic
regions, we found no effect of PfSIP2-N over-expression on global
gene transcription. Instead, our results imply major roles for
PfSIP2-N in var gene silencing and chromosome end biology.
Results
Purification and Identification of PfSIP2, a P. falciparum
ApiAP2 Protein Interacting with SPE2 Motifs Upstream of
Subtelomeric var Genes
The bipartite SPE2 motif consists of two imperfect 6bp repeats
separated by 4bp and its sequence-specific interaction with the
unknown nuclear protein is only detectable after the onset of
S-phase [50]. We used a high salt schizont stage nuclear extract,
pre-cleared by incubation with single-stranded DNA, to purify
the SPE2-binding activity based on its affinity to immobilized
concatenated SPE2 elements. As control, mutated SPE2M motifs
that are unable to interact with the protein were used [50]. EMSA
monitoring showed that the SPE2-binding activity was efficiently
depleted only after incubation with SPE2 but not SPE2M.
Author Summary
Plasmodium falciparum, like many other unicellular path-
ogens, uses antigenic variation of surface proteins as a
prime mechanism for immune evasion. Subtelomeric gene
families, including the major virulence family var, encode
these antigens, and recent studies highlighted the
important contribution of the specific biology of chromo-
some ends in regulation of their expression. P. falciparum
chromosome ends are enriched in epigenetic marks of
eukaryotic heterochromatin; however, it remains unknown
which proteins and regulatory DNA motifs are involved in
the recruitment and organization of heterochromatin, and
how they contribute to the role of subtelomere biology in
this important pathogen. Here, we present the experi-
mental identification and genome-wide characterization of
PfSIP2, a member of the ApiAP2 family of transcription
factors that are specific to Plasmodium and related
apicomplexan parasites. PfSIP2 binds to a conserved
recognition sequence exclusively in heterochromatic
domains upstream of subtelomeric var genes and within
telomere-associated repeat elements. Our results suggest
important roles for this protein in several aspects of
chromosome end biology, including var gene silencing.
They are furthermore highly relevant for future efforts to
dissect the specific biology of P. falciparum chromosome
ends, and for our understanding of the role of ApiAP2
factors in parasite biology.
A Role for PfSIP2 in Chromosome End Biology
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Likewise, the activity was eluted only from beads carrying SPE2
but not SPE2M motifs (Figure 1A). Total protein eluted from both
beads were precipitated separately, trypsinized and analyzed by
LC-MS/MS. Peptide spectra were searched against a combined
human and P. falciparum annotated protein database using
TurboSequest software [51]. 89 and 82 P. falciparum proteins
represented by two or more unique peptides were identified in the
SPE2- and the SPE2M-bound fractions, respectively (Tables S1
and S2). Interestingly, of the 18 proteins exclusively detected in the
SPE2 sample (Table 1), two proteins belong to the ApiAP2 family
of transcription factors carrying putative sequence-specific AP2
DNA-binding domains, including the second-ranked protein
encoded by PFF0200c. Furthermore, six co-purifying proteins
have predicted roles in DNA and chromatin metabolism. In
contrast, the 15 proteins detected exclusively in the control sample
showed no such enrichment (Table S2). Due to the high peptide
coverage and a temporal expression profile matching the presence
of the SPE2-binding activity in stage-specific nuclear extracts
[50,52,53], we considered PFF0200c the most likely candidate to
encode the SPE2-binding activity.
PFF0200c encodes a large 230kDa protein containing two N-
terminal AP2 domains as the only annotated features (Figure 1B).
However, UV-crosslinking experiments revealed a 70kDa SPE2-
protein complex, which is consistent with an estimated size of 50–
60kDa of the SPE2-binding protein (Figure 1C). This discrepancy,
and the fact that all seven PFF0200c-derived tryptic peptides
mapped to the region containing both AP2 domains (Table S1),
prompted us to consider possible proteolytic processing and release
of a DNA-binding N-terminal fragment. We therefore expressed
epitope-tagged N-terminal fragments of PFF0200c containing
both AP2 domains as recombinant proteins in both P. falciparum
and E. coli (Figure 1B). Nuclear extracts from 3D7/SIP2-N-HA
parasites produced a SPE2-specific complex similar to the one
observed in wild-type parasites (Figure 1D), and anti-HA
antibodies specifically supershifted the complex obtained with
the 3D7/SIP2-N-HA-derived extract only. Similarly, E. coli lysates
containing the same fragment as 66HIS tagged version (SIP2-N-
HIS_A) produced a shift of similar size and specificity that was
supershifted in presence of anti-66HIS antibodies. Consistent with
the smaller size of the SIP2-N-HIS_B protein, we observed a faster
migrating complex of identical specificity. For completeness, we
also expressed a 150kDa protein in P. falciparum containing all
three AP2 domains of the second ApiAP2 protein PF10_0075 but
were unable to detect binding to SPE2 (data not shown). Together,
these results unambiguously identified PFF0200c as the P.
falciparum SPE2-binding protein, which we termed PfSIP2
(SPE2-interacting protein).
Proteolytic Processing of Inactive Full-Length PfSIP2 is
Required to Release the SPE2-binding N-terminal
Fragment PfSIP2-N
As indicated by gel shift and UV-crosslinking experiments, the
sizes of the endogenous PfSIP2 activity and the N-terminal
PfSIP2-N-HA protein were of similar size. To test if PfSIP2 is at all
expressed as a full-length protein we generated a transgenic line
expressing C-terminally tagged full-length PfSIP2 from the
endogenous locus (3D7/SIP2-Ty) (Figure S1). Western analysis
of nuclear extracts identified a 250kDa band, consistent with the
predicted size of full-length PfSIP2-Ty, specifically in early and
late schizonts (Figure 1E, top panel). An additional 150kDa C-
terminal fragment (SIP2-C-Ty) appeared in late schizonts
indicating that indeed a specific proteolytic event releases an N-
terminal DNA-binding isoform. In line with this result, the same
early and late schizont extracts produced a typical SPE2/PfSIP2-
N complex in EMSA (Figure 1E, bottom panel). These results
further suggested that full-length PfSIP2 is unable to interact with
SPE2 in vitro. To test this, we performed SPE2 pull-down
experiments and confirmed that only N-terminal PfSIP2-N-Ty
bound to SPE2 beads, but not full-length PfSIP2-Ty nor the C-
terminal fragment PfSIP2-C-Ty (Figure 1F). Together, these
results substantiate the existence of a specific proteolytic event to
activate the release of the functional DNA-binding protein PfSIP2-
N during schizogony.
PfSIP2-N Co-localizes with PfHP1 to Chromosome End
Clusters and Interacts with SPE2 Arrays Upstream of var
Genes in vivo
Since SPE2 arrays occur in conserved positions upstream of
subtelomeric upsB var genes we expected PfSIP2-N to mark
chromosome end clusters. Consistent with this assumption,
indirect immunofluorescence (IFA) microscopy identified discrete
PfSIP2-N-HA foci at the nuclear periphery with increasing
numbers of foci in replicating stages (Figure 2A). To confirm that
these signals indeed represented chromosome end clusters we
compared the PfSIP2-N-HA signals with those of the heterochro-
matic marker PfHP1 [27] in a double transgenic line co-expressing
PfSIP2-N-HA and PfHP1-Ty simultaneously. As expected,
double-labeling IFAs revealed that both proteins co-localized at
the nuclear periphery (Figure 2B). Next, we tested if PfSIP2-N
binds to SPE2 elements in vivo by targeted chromatin immuno-
precipitation (ChIP-qPCR). We observed specific enrichment of
PfSIP2-N-HA at the SPE2 array upstream of the upsB var gene
PFL0005w while three regions further downstream showed no
association (Figure 2C). Together, these findings demonstrate that
PfSIP2-N binds specifically to SPE2 arrays upstream of upsB var
genes in vivo.
We recently demonstrated that var gene promoters driving
expression of the drug-selectable marker hdhfr are silenced by
default. Challenge with the antifolate WR99210 allowed selection
for activated promoters, which displayed a ring stage-specific
temporal activity profile similar to the endogenous promoters
[24,54]. To explore if PfSIP2 participates in the regulation of upsB
var gene promoters, we used quantitative reverse transcriptase-
PCR (qRT-PCR) to compare the activities of an episomal upsB
promoter and a truncated version lacking a 500bp region
containing the entire SPE2 array in transfected parasites lines
3D7/upsBR [54] and 3D7/upsBRDSPE2, respectively, in a time
course experiment (Figure S2). As expected, the default state of the
wild-type upsB promoter in 3D7/upsBR was silenced. Interest-
ingly, deletion of the region including the SPE2 array resulted in a
ten-fold increase in default activity in all three ring stage samples,
which is in line with previous results obtained by transient
transfection [50]. In their activated states, however, both
promoters displayed strong and almost identical activities and
temporal profiles (Figure S2). These findings indicate that PfSIP2
may contribute to, but is not the only determinant of, upsB
promoter-mediated silencing, and has no role in stage-specific var
promoter activity.
The Interaction of PfSIP2-N with SPE2 is Highly
Sequence-Specific and Dependent on the Bipartite
Nature of Both Interacting Partners
As an important step towards understanding the role of PfSIP2-
N in parasite biology, we were interested in scrutinizing the
specificity of the PfSIP2-N/SPE2 interaction. Our earlier work
demonstrated that two point mutations in either half of the
bipartite SPE2 sequence abrogated binding [50]. Intriguingly, a
A Role for PfSIP2 in Chromosome End Biology
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Figure 1. Identification of the ApiAP2 protein PfSIP2 as the SPE2-interacting protein. (A) Gel shift assay to test the course of affinity
purification. Lane 1: probe only; lane 2: nuclear extract (input); lanes 3–5: supernatants after incubation of nuclear extract with beads carrying single-
stranded DNA (3), SPE2 (4) or mutated SPE2M (5); lanes 7–10: proteins eluted from SPE2-loaded beads (SPE2 E). Lanes 11 and 12: A second eluate
(SPE2 E2) and proteins bound to mutated SPE2M (SPE2mut E) contain no SPE2-binding activity. Faster migrating bands are probably due to
degradation of PfSIP2-N during affinity purification. (B) Schematic representation of the ApiAP2 protein PfSIP2 encoded by PFF0200c and
recombinant epitope-tagged PfSIP2 proteins expressed in either P. falciparum (SIP2-Ty; SIP2-N-HA; SIP2-N-Ty) or E. coli (SIP2-N-HIS_A; SIP2-N-HIS_B).
Dark and light blue boxes indicated AP2 domains 1 and 2. (C) Size estimation of the endogenous SPE2-binding activity in parasite nuclear extracts by
UV-crosslinking. The arrow highlights the size of the crosslinked DNA-protein complex (lanes 2 and 4). Complex formation is competed by a 25-fold
molar excess of SPE2 (lane 3) but not by mutated SPE2M (lane 4). The DNA-protein complex is not observed in absence of radiolabeled SPE2 (lane 1)
or without prior UV-crosslinking (lane 5). (D) Gel shift assay to confirm the identity of PFF0200c as the SPE2-binding protein. Lane 1: probe only; lanes
2–5: 3D7 nuclear extract; lanes 6–9: nuclear extract of 3D7/SIP2-N-HA over-expressing SIP2-N-HA (aa 1–387); lane 10: untransformed E. coli control
lysate; lanes 11–14: lysate of E. coli expressing recombinant SIP2-N-HIS_A (aa 1–387); lanes 15–18: lysate of E. coli expressing recombinant SIP2-N-
HIS_B (aa 171–387). Lanes 3, 7, 12 and 16: 100-fold molar excess of unlabeled SPE2 competitor. Lanes 4, 8, 13 and 17: 100-fold molar excess of
mutated competitor SPE2M. Lanes 5, 9, 14 and 18: EMSA supershift in presence of anti-HA or anti-66HIS antibodies. (E) Anti-Ty Western blot of 3D7/
SIP2-Ty nuclear extracts prepared at five consecutive timepoints during the intra-erythrocytic developmental cycle (IDC). Expression of full-length
PfSIP2-Ty and subsequent processing occur during schizogony. The bottom panel shows the presence of PfSIP2-N by EMSA in schizont extracts.
Protein extracted from equal numbers of nuclei were used in each lane. hpi: hours post-invasion. (F) Pull-down of full-length PfSIP2-Ty and PfSIP2-N-
Ty based on affinity to SPE2. PfSIP2-N-Ty binds efficiently to immobilized SPE2 whereas neither full-length PfSIP2-Ty nor the C-terminal processed
fragment PfSIP2-C-Ty interact with SPE2. None of the proteins bound to mutated SPE2M DNA. SN: supernatant.
doi:10.1371/journal.ppat.1000784.g001
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recent study identified GTGCA (which is identical to the first half
of the bipartite SPE2 sequence) as consensus motif for PfSIP2-N
[48]. These authors also argued that the first AP2 domain alone
was sufficient for binding. To clarify these conflicting results, we
compared the ability of PfSIP2-N to bind to a bona fide SPE2 motif
and to a DNA sequence of identical length carrying the GTGCA
motif only. Figure 3A shows that under identical conditions
PfSIP2-N binds only to SPE2 but not GTGCA. We next
speculated that the bipartite nature of both the SPE2 element
and PfSIP2-N with two adjacent AP2 domains reflects the strict
requirement of both intact modules for successful interaction. We
expressed both AP2 domains separately or in combination as
GST-fusions in E. coli and used gel shift assays to confirm that
indeed both adjacent AP2 domains are required for binding
(Figure 3B, right panel).
Next, we used gel shift competition assays to pinpoint as
accurately as possible the minimal sequence requirements for a
functional SPE2 consensus motif (Figure 3C and S3). A first set of
16 competitors incorporated single or multiple base deviations
within the first and/or second half, and tested the importance of
spacing between the half sites. The only changes tolerated were G
to C at position one or two in the first or second repeat,
respectively; all other changes completely averted binding. The
spacing between the half sites was also critical with only four base
pairs tolerated. A second set of competitors included eleven SPE2-
like motifs naturally occurring upstream of genes coding for
invasion-related proteins [55], and two untested SPE2 versions
naturally present in SPE2 arrays upstream of var genes (M1.C1,
M1.A1C2). Only three motifs competed efficiently (rap3, rhoph3,
M1.A1C2) and two competed moderately (MAL6P1.292, M1.C1).
These motifs are most closely related to the original SPE2
sequence. Furthermore, in two instances a 5bp spacer was
tolerated. Interestingly, the rap2 (non-competing) and rap3
(competing) sequences are identical except for the fifth base in
the spacer, indicating that these positions can also contribute to
specificity. The competition EMSAs were repeated several times
with independent batches of competitors and input protein (both
nuclear extracts and E. coli lysates) and yielded identical results
(Figure S3 and data not shown). This high degree of sequence-
specificity of the PfSIP2-N/SPE2 interaction allowed us to deduce
a functional SPE2 consensus motif (Figure 3C). Genome-wide in
silico prediction using the consensus motif as query revealed a
striking distribution of 777 putative PfSIP2-N binding sites
throughout the genome (Tables S3 and S4). 330 sites (42.5%)
are associated with the full set of 24 upsB var genes encoded in the
genome. The majority of these (262) occur in sense-oriented
tandem arrays approx. 2.2kb upstream of 23 subtelomeric upsB
loci with an average of eleven motifs spaced by 12bp per locus, and
the only chromosome-internal upsB var gene contains two
upstream SPE2 sites. 66 sites define a second highly conserved
cluster of upsB-associated SPE2 sites approx. 2.7 kb upstream of
every subtelomeric locus. Interestingly, 393 sites (51.7%) are
located in TAS concentrated in the TARE2/3 region on every
chromosome end, with conserved position and orientation and an
average of 18 motifs per chromosome end, most of which are
spaced by 120bp. Figure 3D shows the right end of chromosome
three as a representative example for the conserved arrangement
of subtelomeric SPE2 sites on all chromosome ends. Of the
remaining 45 sites (5.8%), 30 are located as single motifs in sense
orientation upstream of mainly centrally located single copy genes
coding for hypothetical proteins, and 15 sites map to coding
regions or introns. In summary, this analysis identified a surprising
pattern of putative PfSIP2-N-binding sites throughout the
genome, with 94% of all predicted motifs confined to two major
landmark regions in the subtelomeric domains of P. falciparum
chromosomes.











PF11_0099 heat shock protein DnaJ homologue Pfj2 1.15E-12 70.32 62.3 7
PFF0200c transcription factor with AP2 domains 5.23E-07 70.24 229.5 7
PF08_0054 heat shock 70 kDa protein 5.65E-07 50.20 73.9 5
PFB0840w replication factor C, subunit 2 4.29E-11 30.26 37.9 3
PF13_0143 phosphoribosylpyrophosphate synthetase (PRS) 1.01E-10 30.25 49.4 3
PF10_0323 early transcribed membrane protein 10.2 2.14E-06 30.19 38.9 3
PFE0675c deoxyribodipyrimidine photolyase, putative 1.64E-04 30.13 129.1 3
PF13_0082 cop-coated vesicle membrane protein p24 precursor, putative 4.43E-08 20.27 24.4 2
PFC0250c AP endonuclease, putative 2.06E-08 20.23 72.4 2
PF10_0075 transcription factor with AP2 domains 6.60E-08 20.22 182.6 2
MAL8P1.146 filament assembling protein, putative 5.61E-14 20.18 86.7 2
PFD0080c PHIST domain protein 2.00E-05 20.17 60.2 2
MAL13P1.63 P. falciparum asparagine-rich protein 3.49E-06 20.16 139.0 2
PF11_0433 hypothetical protein 1.14E-06 20.16 324.6 2
PFF1470c DNA polymerase epsilon, subunit A 3.62E-04 20.14 344.4 2
PF07_0040 lysophospholipase, putative 7.46E-04 20.13 42.3 2
PFB0915w liver stage antigen 3 6.10E-04 20.12 175.6 2
PF11_0053 PfSNF2L 3.61E-11 16.24 167.4 2
aAccession numbers (www.plasmodb.org) of proteins exclusively detected in the SPE2-bound fraction (excluding seven annotated and putative ribosomal proteins).
Proteins associated with DNA binding or metabolism are highlighted in bold.
doi:10.1371/journal.ppat.1000784.t001
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Figure 2. PfSIP2-N localizes to P. falciparum chromosome end clusters. (A) IFA detects discrete perinuclear PfSIP2-N-HA signals in late trophozoites
(LT) and early (ES) and late (LS) schizont stage 3D7/SIP2-N-HA parasites. The expression cassette is schematically depicted on the left. (B) Co-localisation of
PfSIP2-N with PfHP1-containing subtelomeric heterochromatin in late trophozoites (LT) and early (ES) and late (LS) schizonts in the double transgenic
parasite line 3D7/SIP2-N-HA/HP1-Ty (over-expressing both proteins as epitope-tagged versions simultaneously). Expression cassettes are schematically
depicted on the left. (C) Targeted ChIP-qPCR analysis demonstrates the specific binding of PfSIP2-N-HA to SPE2 upstream of upsB var gene PFL0005w in
3D7/SIP2-N-HA. Fold enrichment of cross-linked PfSIP2-N-HA-associated chromatin was determined for five regions across the PFL0005w locus. Values
represent the mean of three independent experiments (error bars indicate the standard deviation). The location of the SPE2 repeat array and the positions
of qPCR primers are indicated by nucleotide positions with respect to the ATG start codon. 3D7 wild-type parasites were used as negative control.
doi:10.1371/journal.ppat.1000784.g002
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Figure 3. Binding of PfSIP2-N to SPE2 is highly sequence-specific and requires a bipartite motif and both adjacent AP2 domains. (A)
SIP2-N in 3D7 nuclear extracts binds only to the bipartite SPE2 motif but not to a probe of identical length containing the SPE2 half site GTGCA only
(GATACATGTGCAAACATGAA). C: SPE2/PfSIP2-N complex. (B) Both AP2 domains are required for binding of PfSIP2-N to SPE2. Left panel: Coomassie-
stained SDS-PAGE gel showing recombinantly expressed PfSIP2-GST fusions in E. coli lysates. Lane 1: non-induced control lysate; lane 2: SIP2-AP2_1
consisting of the first AP2 domain only (aa 174–252); lane 3: SIP2-AP2_2 carries the second AP2 domain only (aa 231–311); lane 4: SIP2-AP2_12
contains both adjacent AP2 domains (aa 174–311). Right panel: EMSA showing that single isolated AP2 domains are unable to bind to SPE2 and that
both AP2 domains are required for binding. C: SPE2/PfSIP2-GST complex. (C) Competition EMSA using recombinant SIP2-N-HIS_B to determine the
minimal sequence requirements for binding of PfSIP2-N to a SPE2 consensus site. The gel was rotated by 90u clockwise for simpler display (the arrow
on top indicates the direction of electrophoretic separation). Lane 1: radiolabeled 28bp SPE2 probe only; lane 2: SPE2/PfSIP2-N-HIS_B interaction in
absence of competitor; lanes 3–19: SPE2/PfSIP2-N-HIS_B interaction in presence of a 50-fold molar excess of specific competitors. The names and
sequences of all competitors (all 28bp) are indicated to the left. The dashed lines group competitors into artificially mutated SPE2 motifs or into
naturally occurring SPE2-like elements upstream of P. falciparum invasion genes [55] or upsB promoters (M1.C1, M1.A1C2). Altered nucleotides in the
left or right half site of the original SPE2 sequence are highlighted in red. Additional nucleotides in the 4bp spacer are indicated in green. Red squares
identify competitors unable to interact with PfSIP2-N-HIS_B, green squares highlight competitors that were able to compete with the SPE2/PfSIP2-N-
HIS_B interaction. The experimentally determined SPE2 consensus site is shown at the bottom. (D) SPE2 consensus motifs define subtelomeric
landmarks at P. falciparum chromosome ends. The position of all SPE2 motifs (arrowheads) at the right end of chromosome 3 is shown. Blue and
purple arrowheads represent SPE2 motifs with four and five bp spacing between the half sites, respectively. Arrowhead orientation indicates the
presence of SPE2 motifs on the sense or antisense strand. T1-T6: TARE 1 to 6. The telomere is depicted as a black box. The upsB var gene PFC1120c
represents the first coding sequence downstream of TARE6. See also Tables S3 and S4 for more information. Chromosomal coordinates are according
to PlasmoDB version5.5 annotation (www.plasmodb.org).
doi:10.1371/journal.ppat.1000784.g003
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In vivo Binding of PfSIP2-N is Restricted to Subtelomeric
SPE2 Landmarks in TAS and Upstream of UpsB-type var
Genes
To test our in silico prediction and to identify potential additional
PfSIP2-N target sites we performed genome-wide ChIP (ChIP-on-
chip) on a high-density whole genome tiling array (NimbleGen
Systems Inc.) [27,37]. Comparison of the genome-wide PfSIP2-N-
HA occupancy pattern with the in silico prediction revealed a high
degree of overlap (Figure 4 and Table S3). Strikingly, the in vivo
association of PfSIP2-N-HA was restricted to SPE2 sites in the
predicted landmarks in TARE2/3 and upstream of subtelomeric
var genes, both of which are located within H3K9me3/PfHP1-
enriched heterochromatin [23,27,37]. In contrast, none of the
chromosome-internal sites was bound by PfSIP2-N-HA and we
observed no enrichment of PfSIP2-N-HA at non-SPE2 loci.
To validate the ChIP-on-chip data we performed ChIP-qPCR
on selected loci in 3D7/SIP2-N-HA schizont stage parasites.
Figure 5A shows that in addition to SPE2 upstream of upsB var
genes (see Figure 2C), PfSIP2-N-HA was also bound to TARE2/3,
and interestingly also to the only internal upsB var locus PFL0935c
containing two juxtaposed SPE2 motifs. However, we found no
specific enrichment at five promoters of internal genes carrying a
single SPE2 site. As negative control, we tested the promoters of
five genes that are not associated with SPE2. To confirm these
results, and to test the anticipated co-occupancy of PfSIP2-N with
PfHP1, which was previously shown to be enriched at upsB loci
[27], we performed parallel ChIP using chromatin isolated from
3D7/SIP2-N-HA/HP1-Ty schizonts. Indeed, PfHP1 and PfSIP2-
N were both enriched at a subtelomeric and the internal upsB
locus (Figure 5B), corroborating the findings presented in
Figures 2C and 5A. In independent experiments, we used ChIP-
re-ChIP to directly confirm the co-occupancy of PfSIP2-N and
PfHP1 on the same chromatin fragments in 3D7/SIP2-N-HA/
HP1-Ty parasites (Figure S4). Interestingly, in both instances
PfHP1 showed a marked reduction directly over the SPE2 array at
the PFL0005w locus indicating that in vivo occupancy by PfSIP2-N
might be incompatible with local nucleosome formation.
In summary, our combination of in vitro, in silico and in vivo
characterisation uncovers a highly specific association of PfSIP2-N
with SPE2 consensus motifs on a genome-wide level. The exclusive
local restriction of this interaction to telomere-proximal non-
coding regions implies important structural and functional roles
for PfSIP2-N in subtelomeric heterochromatin formation and
chromosome end biology.
Over-expression of PfSIP2-N has no Effect on
Transcriptional Regulation of Putative Target Genes
To test a possible role for PfSIP2-N in transcriptional regulation
by alternative means we compared the global transcript levels in
3D7/SIP2-N-HA parasites to a mock-transfected line at four stages
during the intra-erythrocytic developmental cycle (IDC). Over-
expression of PfSIP2-N-HA was evident by up to eight-fold higher
levels of pfsip2 transcripts in 3D7/SIP2-N-HA compared to the
control (Figure 6). The overall effect of PfSIP2-N-HA over-
expression was surprisingly minor with only 21 genes up- or down-
regulated by more than three-fold in at least one time point. None of
the de-regulated genes is associated with an upstream SPE2 motif
and none of the putative PfSIP2-N target genes identified here or by
others [48,55] was affected, arguing strongly against a role of PfSIP2-
N in transcriptional activation. Most of the affected genes, including
seven non-upsB var genes, are located in heterochromatic regions,
which can be explained by stochastic variation in the expression of
heterochromatic genes between different isogenic cell lines.
Discussion
Sequence-specific DNA-protein interactions serve to target
specific activities to specific sites in the genome and are
instrumental in genome organization and gene regulation. Here,
we identified PfSIP2, a member of the ApiAP2 family of putative
transcription factors, as the unknown nuclear protein binding to
SPE2 tandem arrays upstream of subtelomeric var genes. Our
comprehensive analysis reveals important novel insights into the
nature and specificity of the PfSIP2/SPE2 interaction and
provides compelling evidence for a major role of PfSIP2 in
chromosome end biology.
Surprisingly, we found that the SPE2-binding activity is not
exerted by the full-length protein but rather by a processed N-
terminal fragment, PfSIP2-N. The inability of full-length PfSIP2 to
interact with SPE2 in vitro indicates that the release of PfSIP2-N
does not occur accidentally during extraction but reflects a true
proteolytic cleavage event required to activate the DNA-binding
activity. Our thorough re-definition of the specificity of the
PfSIP2-N/SPE2 interaction in gel shift competition assays allowed
us to determine a highly specific SPE2 consensus motif. Both 6bp
half sites of the bipartite SPE2 element are strictly required for
binding, which is in agreement with our earlier findings [50]. We
also show that both adjacent AP2 domains are necessary for
binding, probably through reinforcing interactions of each domain
with each half of the bipartite motif. Such a scenario is consistent
with the binding of single AP2 domains to single 5–6bp motifs in
Plasmodium [48,49] and plants [56,57], and the specific interaction
of the Arabidopsis tandem AP2-domain protein AINTEGU-
MENTA to a 16bp sequence, which also requires both AP2
domains for binding [58]. These findings challenge the previously
proposed role of PfSIP2 in transcriptional activation of genes
carrying an upstream GTGCA motif [48]. We clearly show that
PfSIP2-N does not bind to GTGCA neither in vitro nor in vivo and,
for that matter, consider PfSIP2-N unlikely to act as transcrip-
tional activator of GTGCA-associated genes. We explain these
conflicting results by fact that the protein binding microarray
technology used in the former study was limited to the screening of
random 10mers only, which precluded identification of the 16bp
SPE2 element as high affinity binding motif. Our results are highly
relevant for our understanding of the role of PfSIP2 in parasite
biology, and provide important information for the future
investigation of specific ApiAP2-DNA interactions.
Our genome-wide in silico prediction identified 777 PfSIP2-N
target sites, 94% of which are located in two distinct landmark
regions within subtelomeric heterochromatin on all chromosomes.
One cluster corresponds to the previously described tandem arrays
upstream of subtelomeric var genes [50], and a second newly
identified cluster lies within TARE2/3. In addition, we detected
30 internal SPE2 sites located upstream of single copy genes.
Importantly, genome-wide and targeted ChIP analysis of PfSIP2-
N occupancy correlated strongly with the in silico prediction of
subtelomeric target sites, showing that both subtelomeric land-
mark regions were bound by PfSIP2-N in vivo. In contrast, PfSIP2-
N was absent at internal sites, except for the only internal upsB
locus with two upstream SPE2 motifs. Therefore, binding of
PfSIP2-N is restricted to heterochromatic regions including the
entire subset of upsB var genes. The co-localization of PfSIP2-N
with PfHP1 at perinuclear chromosome end clusters and upstream
of upsB var genes corroborates this exclusive association. The
observed increase in default upsB promoter activity upon deletion
of the SPE2 array suggests a role for PfSIP2-N in var gene
silencing, possibly through direct or indirect recruitment of effector
proteins. However, the overall distribution pattern of PfSIP2-N
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implies important roles in structural and functional organization
and maintenance of P. falciparum chromosome ends that go beyond
regulating var gene expression.
In contrast to the well-established and conserved roles of
telomere repeat-binding proteins ScRAP1, SpTAZ1, HsTRF1/2
in telomere position effect, telomere length regulation and
Figure 4. PfSIP2-N binds to SPE2 landmarks in subtelomeric regions of P. falciparum chromosomes in vivo. (A) Genome-wide PfSIP2-N-
HA occupancy as determined by high-density ChIP-on-chip. Schematic display (SignalMap) and localization of genomic regions bound by PfSIP2-N-
HA in 3D7/SIP2-N-HA schizont stage parasites (blue lines) and the position of predicted SPE2 consensus sites (red lines) on all 14 parasite
chromosomes. Genomic regions were considered occupied by PfSIP2-N-HA if the average of log2 ratios (ChIP over input) for all probes in a 1000bp
window was higher than 1.4. Chromosome numbers are indicated on the left, chromosomal positions on top. Solid black lines indicate regions not
represented on the microarray (see also Table S3). (B) Regional zoom-in of the PfSIP2-N-HA ChIP-on-chip profile and predicted SPE2 motifs at the left
arm of chromosome 10. PfSIP2-N-HA-occupied regions (peaks) have been identified by the built-in algorithm of SignalMap as explained above. The
locations of the upsB var gene and downstream rif genes are indicated below. Chromosomal coordinates are according to PlasmoDB version5.5
annotation (www.plasmodb.org).
doi:10.1371/journal.ppat.1000784.g004
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heterochromatin formation in yeasts and humans, respectively
[2,59–64], specific DNA-protein interactions in TAS are hardly
known and have only been investigated in detail in S. cerevisiae.
One such factor is ABF1, which is involved in silencing, initiation
of DNA replication, alteration of chromatin structure and
nucleotide excision repair [65–70]. Our results are in agreement
with similar roles of PfSIP2-N in P. falciparum. First, multiple
attempts to generate a PfSIP2 knockout line failed due to
refractoriness of the pfsip2 locus to disruption (data not shown).
Since pfsip2 was readily accessible for 39 replacement, we believe
PfSIP2 is essential for parasite survival. Second, given the close
connection between DNA replication and heterochromatin
formation, the specific co-purification of several DNA replica-
tion/repair and chromatin remodeling factors (RFC, DNA pol e,
SNF2L, PRS) with PfSIP2-N (Table 1) supports a role in
chromosome end maintenance. DNA pol e and RFC, as well as
members of the ATP-dependent chromatin remodeling complexes
SWI/SNF, are central players in chromosome end replication and
repair [71–75] and have important roles in silencing [76,77].
Interestingly, these factors are also associated with DNA repair at
stalled replication forks [78,79], which can be induced by tight
DNA-protein interactions and are crucially involved in recombi-
nation at rDNA repeats and mating type switching in S. cerevisiae
and S. pombe, respectively [80]. Third, PfSIP2 expression and
subsequent release of PfSIP2-N correlate with the DNA replication
and nuclear division cycles during schizogony, and it is tempting to
speculate that proteolytic activation of PfSIP2-N may occur in a
cell cycle-dependent manner. A similar process has been described
in activation of the CDP/Cut transcription factor by S phase-
specific cleavage [81], and proteolytic processing of various targets,
Figure 6. Overexpression of PfSIP2-N-HA has no effect on global
gene transcription. Global transcript profiles in 3D7/SIP2-N-HA
parasites were compared to the control line 3D7/camHG [27] at four
timepoints across the IDC. TP1: ring stages 4–14 hours post-invasion (hpi);
TP2: late ring stages 14–24 hpi; TP3: trophozoites 24–34 hpi; TP4:
schizonts 32–42 hpi. All genes transcribed at greater 3-fold difference in
3D7/SIP2-N-HA compared to the control in at least one timepoint are
listed. Over-expression of pfsip2-n is shown on top. The heat map
indicates fold differences in transcript abundance on a gradual scale
(green: down-regulated; red: up-regulated). Gene annotations are listed to
the right and are according to PlasmoDB version5.5 (www.plasmodb.org).
doi:10.1371/journal.ppat.1000784.g006
Figure 5. PfSIP2-N-HA binds exclusively to SPE2 elements
located in heterochromatic TARE2/3 and upsB var gene
domains. (A) PfSIP2-N-HA binds exclusively to SPE2 sites in TARE2/3
and upstream of upsB var genes. A region located between TARE2 and
TARE3, the regions upstream of the only internal upsB var gene
PFL0935c, promoters of five loci carrying predicted SPE2 consensus
sites, and promoters of five genes lacking a SPE2 consensus site were
tested by ChIP-qPCR for in vivo binding of PfSIP2-N-HA. qPCR primers
were directed against upstream regions (represented by horizontal lines
with arrows). Fold enrichment values represent the mean of three
independent experiments on 3D7/SIP2-N-HA schizont stage samples
(error bars indicate the standard deviation). 3D7 wild-type parasites
were used as negative control. Gene names and accession numbers are
according to PlasmoDB version5.5 (www.plasmodb.org). SPE2 elements
are indicated by thick vertical black lines. (B) PfSIP2-N/SPE2 is
embedded in PfHP1-containing heterochromatin. Parallel ChIP-qPCR
was performed on 3D7/SIP2-N-HA/HP1-Ty schizont stage parasites
using anti-HA and anti-Ty antibodies to test for occupancy by PfSIP2-N-
HA and PfHP1-Ty, respectively. Normal rabbit IgG was used as negative
control for ChIP. qPCR primers were directed against upstream regions
(represented by horizontal lines with arrows). Vertical thick lines
indicate the presence of SPE2 consensus sites. PfSIP2-N-HA and
PfHP1-Ty co-occupancy at these loci was confirmed by ChIP-re-ChIP
in independent experiments (Figure S4).
doi:10.1371/journal.ppat.1000784.g005
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including cyclins, DNA replication factors and cohesin is an
important regulatory strategy in cell cycle progression [82]. In
summary, these results and observations are consistent with a
potential multifunctional role of PfSIP2-N in chromosomal
replication and/or segregation and in the nucleation of sub-
telomeric heterochromatin on newly replicated chromosomes.
ApiAP2 factors have been proposed to act as regulators of stage-
specific expression [47,48], and this was experimentally demon-
strated for AP2-O in P. berghei ookinetes [49]. We mapped 45
SPE2 consensus sites in internal regions, mostly located upstream
of single copy genes that are transcribed late during the IDC
(Table S5). Another study identified SPE2-like motifs upstream of
eleven genes coding for invasion-related proteins with similar
expression profiles [55]. Interestingly, our ChIP experiments failed
to reveal binding of PfSIP2-N to any of these sites. Although we
cannot exclude that this lack of association is due to insufficient
ChIP sensitivity or physical masking of the HA epitope at internal
loci, we believe this finding reflects the true absence of this protein
since PfSIP2-N was undoubtedly bound to the only chromosome-
central upsB var locus carrying two SPE2 motifs. In addition, over-
expression of PfSIP2-N had no effect on transcription of any of
these genes. These observations are clearly inconsistent with a role
for PfSIP2-N in transcriptional activation. However, we do not
rule out a possible function of full-length PfSIP2 in regulation of
target loci. First, given the overlap in expression of PfSIP2 with
that of SPE2-asscociated genes, a role for PfSIP2 in their
activation is conceivable. Although full-length PfSIP2 did not
bind to SPE2 in vitro, it is still possible that PfSIP2 binds to and
regulates target sites in vivo, possibly in association with other
factors. Second, deletion of the SPE2 motif from the rap3 promoter
resulted in reduced activity [55] and, conversely, introduction of
SPE2 into a heterologous promoter activated transcription in late-
stage parasites [54]. Third, PfSIP2 orthologs exist in a subset of
other apicomplexan parasites including all sequenced Plasmodium
species, yet subtelomeric SPE2 arrays are unique to P. falciparum.
In the P. vivax and P. knowlesi genomes, for instance, we predicted
120 and 80 SPE2 consensus sites, respectively, all of which occur
as single sites mostly in chromosome-internal regions (data not
shown). Hence, if SIP2 has the same binding specificity in other
species (which is likely due to the remarkable sequence identity in
their DNA-binding domains) then SIP2 must have a function
other than being involved in subtelomere biology. It will be
interesting to test if processing of PfSIP2 reflects a specific gain-of-
function process during evolution of the P. falciparum lineage in
order to cope with the massive expansion and control of
subtelomeric virulence gene families.
In conclusion, we have identified the first sequence-specific
component of subtelomeric regions in P. falciparum. To the best of
our knowledge, PfSIP2-N/SPE2 represents a novel type of
sequence-specific interaction at chromosome ends that has not
been reported in any other eukaryote. Our results are highly
relevant in the dissection of the specific biology of P. falciparum
chromosome ends, which is key to the evolution and variable
expression of subtelomeric virulence gene families, and will help to
understand similar processes in other systems. Efforts to analyze a
loss-of-function phenotype and to identify PfSIP2 interaction
partners will be important future steps into this direction.
Materials and Methods
Parasite culture and transfection
P. falciparum 3D7 parasites were cultured as described previously
[83]. Growth synchronisation was achieved by repeated sorbitol
lysis [84]. Transfection constructs are described in Protocol S2.
Transfections were performed as described [24] and selected on
either 5mg/ml blasticidin-S-HCl or 4nM WR99210, or both. To
obtain C-terminally tagged endogenous PfSIP2 parasites trans-
fected with pSIP2-26Ty_39RP were subject to 3 cycles of growth
in presence and absence of WR99210. Plasmid integration was
verified by Southern analysis.
Nuclear extracts and EMSA
High salt nuclear extracts and EMSAs were prepared and
carried out as described [50] (see also Protocol S1). E. coli lysates
were diluted to avoid excess input of recombinant protein.
Competition EMSAs were performed in presence of non-specific
competitor DNA (1mg sheared salmon sperm DNA and 200fmol
random 30 base ss oligonucleotide per reaction) and a 50- to 100-
fold molar excess of specific ds competitors.
UV-crosslinking
Protein samples were incubated for 20min in EMSA buffer with
20fmol 32P-labeled SPE2 probe in presence or absence of a 25-fold
molar excess of SPE2 or SPE2M competitors. DNA-protein
interactions were UV-crosslinked for 60min (107 Joule) in a
Stratalinker 1800 (Stratagene) and separated by SDS-PAGE. Gels
were directly exposed to X-ray film.
Affinity purification and identification of the SPE2-
binding protein
The complete protocol is explained in detail in Protocol S1.
Briefly, the SPE2-binding activity was purified by incubation of
schizont stage nuclear extracts with streptavidin magnetic beads
carrying immobilized biotinylated SPE2 or SPE2M elements (see
Protocol S4 for oligonucleotide sequences). Bound proteins were
eluted with 2M KCl, precipitated with 10% TCA and dissolved in
50ml 100 mM Tris-HCl, pH 8.0. Proteins were digested with
trypsin and analysed by capillary liquid chromatography tandem
mass spectrometry (LC-MS/MS) using an Orbitrap FT hybrid
instrument (Thermo Finnigan, San Jose, CA, USA). MS/MS
spectra were searched against a combined P. falciparum/human
annotated protein database.
Southern blot analysis
To verify successful 39 replacement at the PFF0200c locus,
gDNA from 3D7 wild-type parasites and drug-cycled 3D7/SIP2-
Ty parasites was digested with BamHI and HindIII and analysed by
Southern blot. The blot was probed with a 32P-dATP-labeled
702bp fragment derived from the 39 end of PFF0200c.
Recombinant protein expression
Plasmids are described in Protocol S2. Recombinant proteins
were expressed in E. coli Tuner (DE3) cells (Novagen) replicating
pMICO [85]. After 4h induction using 1mM IPTG at 30uC,
bacteria were pelleted and resuspended in 50mM Tris-HCl
(pH7.5) containing protease inhibitors (Roche Diagnostics). The
suspension was frozen, thawed and sonicated. NaCl, Triton X-
100, b-ME and glycerol were added to final concentrations of
0.3M, 0.5%, 10mM and 5%, respectively, followed by centrifu-
gation for 15min at 15,000g and 4uC. Supernatants were used in
gel shift assays without further purification.
Western blot analysis and protein pulldown
Primary antibody dilutions were: anti-HA 3F10 (Roche
Diagnostics) 1:2,000; anti-Ty BB2 (kind gift of K. Gull)
1:10,000; anti-66HIS (R&D Systems) 1:5,000. High salt nuclear
extracts from 3D7/SIP2-Ty and 3D7/SIP2-N-Ty schizonts were
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incubated for 1hr with streptavidin agarose beads carrying
immobilized SPE2 or mutated SPE2M motifs in EMSA buffer
supplemented with non-specific competitor DNA. After centrifu-
gation at 2000rpm the supernatant was saved and beads washed
three times in binding buffer. Bound proteins were eluted with 2M
KCl.
Immunofluorescence assays
Methanol-fixed cells were analysed using rat anti-HA 3F10
(1:100) or mouse anti-Ty BB2 (1:1,000) antibodies. Alexa-FluorH
568-conjugated anti-rat IgG (Molecular Probes) 1:500; FITC-
conjugated anti-mouse IgG (Kirkegaard Perry Laboratories)
1:300; TexasRed-conjugated anti-mouse IgG (Molecular Probes)
1:500. Images were taken on a Leica DM 5000B microscope with
a Leica DFC 300 FX camera and acquired via the Leica IM 1000
software and processed and overlayed using Adobe Photoshop
CS2.
Genome-wide SPE2 prediction
To identify the full complement of SPE2 consensus elements in
P. falciparum, P. vivax and P. knowlesi, genome sequences available at
PlasmoDB (version5.5) were searched using the PfSIP2-N-binding
consensus sequence determined in competition gel shift assays
(Figure 3C and Figure S3). A regular expression search engine
(DREG) from the EMBOSS software package was used.
ChIP and ChIP-on-CHIP
ChIP and ChIP-on-chip using formaldehyde-crosslinked chro-
matin was performed as described in detail elsewhere [27].
PfSIP2-N-HA enrichment at selected loci was tested by ChIP-
qPCR using three independent chromatin preparations isolated
from 3D7/SIP2-N-HA parasites, and by ChIP- and ChIP-re-
ChIP-qPCR using two independent chromatin preparations
isolated from the double-transfectant 3D7/SIP2-N-HA/HP1-Ty
(qPCR primers are listed in Protocol S4). Enrichment values were
calculated by dividing the recovery values obtained by ChIP with
anti-HA 3F10 (Roche Diagnostics)/anti-Ty BB2 antibodies with
that of the non-specific control IgG antibody. For ChIP-re-ChIP,
chromatin fragments immuno-precipitated with anti-Ty BB
antibodies were eluted with 50ml elution buffer (1% SDS and
0.1M NaHCO3). After incubation at 65uC for 10min to inactivate
the BB2 antibody, the eluate was diluted 66 in incubation buffer
lacking SDS (resulting in SDS concentration comparable to that of
the first ChIP). Re-ChIP reactions were carried out in the presence
of 0.2mg/ml Ty peptide to avoid immuno-precipitation by the
BB2 antibody carried over from the first ChIP. Recovery values
were defined in the percentage of the input material of the first
ChIP. For genome-wide analysis, immunoprecipitated DNA was
amplified by a modified T7 linear amplification method and
analyzed on a tiling array (based on the May 2005 NCBI sequence
of the P. falciparum genome; 385,000 probes with a median spacing
of 48bp, Roche NimbleGen) [37].
Quantitative reverse transcriptase PCR
qPCR was performed on reverse transcribed total RNA and
gDNA isolated from synchronous parasite cultures at six time-
points across the IDC. A detailed protocol, relative transcript
calculation and primer sequences are provided in Protocols S3 and
S4.
Transcriptional profiling and data analysis
Growth of 3D7/SIP2-N-HA parasites was tightly synchronized
in parallel three times by sorbitol treatment to achieve a ten-hour
growth window. Total RNA was isolated at four timepoints across
the IDC at early ring stages (4–14 hours post-invasion (hpi)), late
ring stages (14–24 hpi), trophozoites (24–34 hpi) and schizonts
(32–42 hpi) by lysis of pelleted RBCs in TriReagent (Sigma).
Transcript levels in 3D7/SIP2-N-HA were compared to those of
the control line 3D7/camHG [27]. RNA samples were analyzed
using a P. falciparum microarray as previously described [86]. RNA
from each time point was hybridized against a RNA pool
assembled from equal amounts of total RNA collected from the
3D7 strain at every eight hours across the IDC.
Accession numbers
PlasmoDB (www.plasmoDB.org) accession numbers for genes and
proteins discussed in this publication are: PfSIP2 (PFF0200c); PfHP1
(PFL1005c); upsB var genes (PFL0005w, PFL0935c); rhoph1/clag2
(PFB0935w); rhoph1/clag3.1 (PFC0120w); rhoph1/clag9 (PFI1730w);
rhoph2 (PFI1445w); rhoph3 (PFI0265c); rap1 (PF14_0102); rap2
(PFE0080c); rap3 (PFE0075c); rama (MAL7P1.208); rnp3 (PFL2505c);
imp, putative (PFF0645c/MAL6P1.292); gap45 (PFL1090w); asp
(PFD0295c); msp1 (PFI1475w); sera4 (PFB0345c); conserved Plasmo-
dium proteins (PFL1025c, MAL7P1.119); RFC, subunit 2
(PFB0840w); PfSNF2L (PF11_0053); DNA pol e, subunit A
(PFF1470c); transcription factor with AP2 domains (PF10_0075).
Supporting Information
Figure S1 C-terminal tagging of endogenous PfSIP2. (A)
Schematic display of the genomic context of PFF0200c encoding
PfSIP2, the C-terminal tagging plasmid pSIP2-2xTy_39RP, and the
integration event. 702bp of the very 39 end of PFF0200c fused in
frame to a sequence coding for the 2xTy tag was used for
homologous recombination into the endogenous locus. BamHI and
HindIII restriction sites were used to digest gDNA from 3D7 and
transfected parasites. Lengths of the resulting DNA fragments in bp
are indicated. (B) Southern blot of BamHI/HindIII-digested genomic
DNA from 3D7 and 3D7/SIP2-Ty parasites demonstrates the
successful 39 end replacement of the endogenous PFF0200c locus.
Lane 1; pSIP2-2xTy_39RP plasmid control; lane 2: 3D7 wild-type
gDNA; lane 3: 3D7/SIP2-Ty gDNA after 2 cycles off and on
WR99210 selection pressure; lane 4: 3D7/SIP2-Ty gDNA after
three cycles off and on drug selection pressure. The membrane was
probed with a 702bp encoding the 39end of PFF0200c.
Found at: doi:10.1371/journal.ppat.1000784.s001 (0.01 MB PDF)
Figure S2 Evidence for an involvement of the PfSIP2/SPE2
interaction in var gene silencing. Reporter constructs testing the
effect of a 500bp deletion including the entire SPE2 array on upsB
promoter activity are depicted on top. Stage-specific promoter
activity was determined by qRT-PCR in absence of WR selection
(default; first graph) and after WR selection (activated; second
graph). X-axis: synchronized cultures were harvested at six
timepoints across the IDC. hpi: hours post-invasion. Y-axis: values
represent relative transcript levels. Absolute hdhfr, msp8 and cam
transcript numbers were divided by those obtained for the
constitutively expressed gene PF13_0170 (www.plasmoDB.org).
hdhfr transcript levels were additionally normalized for differences
in plasmid copy number as determined by qPCR (Protocol S3).
Transcript profiles of msp8 (ring stage-specific marker; third graph)
and calmodulin (expressed in trophozoites and schizonts; last
graph) show comparable stage composition for each parasite line
in each timepoint.
Found at: doi:10.1371/journal.ppat.1000784.s002 (0.02 MB PDF)
Figure S3 Competition EMSA to determine a functional SPE2
consensus site. Competition EMSA using recombinant PfSIP2-N-
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HIS_A to determine the minimal sequence requirements for
binding of PfSIP2-N to a SPE2 consensus site. The gel was rotated
by 90u clockwise for simpler display. Lane 1: radiolabeled 28bp
SPE2 probe only; lane 2: SPE2/PfSIP2-N-HIS_A interaction in
absence of competitor; lanes 3–30: SPE2/PfSIP2-N-HIS_A
interaction in presence of a 100-fold molar excess of specific
competitors. The names of all competitors and the original SPE2
sequence and those of all competitors are indicated to the left. The
dashed lines group competitors into artificially mutated SPE2
motifs and in naturally occurring SPE2-like elements upstream of
P. falciparum invasion genes. Altered nucleotides in the left or right
half site of the original SPE2 sequence are highlighted in red.
Additional nucleotides in the 4bp spacer are indicated in green.
The arrow on top indicates the direction of electrophoretic
separation. Red squares identify competitors unable to interact
with PfSIP2-N_HIS_A, green squares highlight competitors that
were able to compete with the SPE2/PfSIP2-N-HIS_A interac-
tion. The experimentally determined SPE2 consensus site is shown
at the bottom.
Found at: doi:10.1371/journal.ppat.1000784.s003 (0.03 MB PDF)
Figure S4 ChIP-re-ChIP shows that PfSIP2-N-HA and PfHP1-
Ty co-localise in subtelomeric heterochromatin. ChIP-re-ChIP
was performed on 3D7/SIP2-N-HA/HP1-Ty schizont stage
parasites. Top panel: Recovery of PfSIP2-N-HA- and PfHP1-
Ty-associated chromatin after the first ChIP using anti-HA and
anti-Ty antibodies, respectively, compared to the negative control
(rabbit IgG). Second panel: Chromatin fragments immuno-
precipitated with anti-Ty antibodies in the first ChIP were used
as input and were re-ChIPped using anti-HA, anti-Ty and rabbit
IgG antibodies in presence of competing Ty peptide. Efficient and
specific peptide competition is evident from the failure to
precipitate chromatin with anti-Ty antibodies in presence, but
not in absence, of Ty peptide. Re-ChIP using anti-HA antibodies
shows that PfSIP2-N-HA is present on PfHP1-Ty-enriched
chromatin but only at loci associated with SPE2 (indicated by
thick vertical lines). Bottom panel: Results from second panel
displayed as fold enrichment values for PfSIP2-N-HA on PfHP1-
Ty-enriched chromatin fragments. qPCR primers were directed
against upstream regions (represented by horizontal lines with
arrows). This experiment was repeated using independently
isolated chromatin and yielded similar results.
Found at: doi:10.1371/journal.ppat.1000784.s004 (0.02 MB PDF)
Table S1 SEQUEST search results of peptide tandem mass
spectra for proteins eluted with SPE2.
Found at: doi:10.1371/journal.ppat.1000784.s005 (0.08 MB PDF)
Table S2 SEQUEST search results of peptide tandem mass
spectra for proteins eluted with SPE2M.
Found at: doi:10.1371/journal.ppat.1000784.s006 (0.08 MB PDF)
Table S3 Genome-wide prediction of SPE2 consensus motifs.
The position of 777 SPE2 consensus motifs experimentally
determined by competition EMSA are listed. Column 1:
Chromosome ID. Column 2: nucleotide position with respect to
the left telomere end of the first bp of the SPE2 motif. Column 3:
nucleotide position of the last bp of the SPE2 motif with respect to
the left telomere on each chromosome. Column 4: ‘‘+’’
denominates positive association of the corresponding SPE2 motif
in the ChIP-on-chip experiment (threshold: min 1,000bp, .1.4
log2 ChIP over input). Column 5: SPE2 orientation on sense (‘‘1’’)
or antisense (‘‘21’’) strand. Column 6: ‘‘tel’’ indicates SPE2
location in TAREs, ‘‘var’’ indicates SPE2 location upstream of
upsB var genes. SPE2 elements associated with genes that do not
fall into the first to classes are identified by PlasmoDB annotation
of the corresponding gene. Column 7: distance in bp to previous
SPE2 motif. Column 8: blank cells represent canonical 4bp
spacing between the two half sites of the bipartite SPE2 motif. ‘‘5’’
represents 5bp spacing. Column 9: PlasmoDB accession numbers
of SPE2-associated genes. Column 10: SPE2 positions other than
in TARE or upstream of coding sequences are indicated. Column
11: orientation of SPE2-associated genes on the sense (‘‘1’’) or
antisense (‘‘21’’) strand. Column 12: nucleotide position of the
ATG start codon of SPE2-associated genes with respect to the left
telomere on each chromosome. Values/information in individual
columns was retrieved from PlasmoDB version 5.5 (www.
plasmodb.org).
Found at: doi:10.1371/journal.ppat.1000784.s007 (0.03 MB PDF)
Table S4 Summary of the genome-wide location of SPE2
elements and their characteristics. Column 1: Classification of
SPE2-associated loci into three groups (var genes, other genes,
TARE). Column 2: The groups classified in column 1 are further
subgrouped according to various criteria (see also Figure 3D).
Column 3: total number of SPE2 sites in each subgroup. Column
4: number of SPE2-associated genes in each subgroup. Column 5:
number of SPE2 sites in each subgroup that are located in either
subtelomeric or chromosome-central positions. Column 6: number
of SPE2 sites in each subgroup in either sense or antisense
orientation with respect to the orientation of the SPE2-associated
gene. Column 7: average distance between, and average number
of, SPE2 sites in SPE2-defined subtelomeric landmarks. Column
8: number of SPE2 sites in each subgroup with either 4bp or 5bp
spacing between half sites. Column 9: relative position of the most
upstream (‘‘first’’) and downstream (‘‘last’’) SPE2 sites upstream of
SPE2-associated genes.
Found at: doi:10.1371/journal.ppat.1000784.s008 (0.01 MB PDF)
Table S5 Single SPE2 sites upstream of internal genes. Column
1: Chromosome ID. Column 2: nucleotide position of the first bp
of the SPE2 motif with respect to the left telomere end. Column 3:
nucleotide position of the last bp of the SPE2 motif with respect to
the left telomere on each chromosome. Column 4: SPE2
orientation on the sense (‘‘1’’) or antisense (‘‘21’’) strand. Column
5: PlasmoDB gene annotation of associated genes. Column 6:
PlasmoDB accession number of associated genes. Column 7:
Location of SPE2 element with respect to the coding sequence.
Column 8: blank cells represent canonical 4bp spacing between
the two half sites of the bipartite SPE2 motif. ‘‘5’’ represents 5bp
spacing. Column 9: orientation of SPE2-associated genes on the
sense (‘‘1’’) or antisense (‘‘21’’) strand. Column 10: nucleotide
position of the ATG start codon of SPE2-associated genes with
respect to the left telomere on each chromosome. Column 11:
distance of SPE2 element in bp upstream of associated genes.
Column 12: Peak transcription. Values/information in individual
columns was retrieved from PlasmoDB version 5.5 (www.
plasmodb.org).
Found at: doi:10.1371/journal.ppat.1000784.s009 (0.02 MB PDF)
Protocol S1 Affinity purification and mass spectrometry-based
identification of the SPE2-interacting protein PfSIP2.
Found at: doi:10.1371/journal.ppat.1000784.s010 (0.03 MB
DOC)
Protocol S2 Plasmid constructs.
Found at: doi:10.1371/journal.ppat.1000784.s011 (0.03 MB
DOC)
Protocol S3 Quantitative reverse transcriptase PCR.
Found at: doi:10.1371/journal.ppat.1000784.s012 (0.03 MB
DOC)
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Protocol S4 Oligonucleotide sequences used in this study.
Found at: doi:10.1371/journal.ppat.1000784.s013 (0.04 MB
DOC)
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